Use of hemostatic drug Spongostan as a carrier of mesenchymal stem cells in the treatment of experimental urinary incontinence in rats
https://doi.org/10.29235/1561-8323-2019-63-4-457-465
Abstract
The adhesion and proliferation of rat adipose-derived mesenchymal stem cells (MSCs) as part of biocomposite with haemostatic drug Spongostan Absorbable Haemostatic Gelatin Powder as well as its regenerative efficiency after its introduction into the periurethral region in rats with experimental urinary incontinence were studied. It was found that MSCs rapidly adhere to the surface of the carrier and actively proliferate. The periurethral injection of biocomposite (Spongostan + MSCs) quickly and effectively recovers the urine continence function in animals that have undergone modeling of incontinence by urethrolysis. Spongostan hydrated in the ratio of 1 :24 inphosphate-saline buffer has a volume-forming effect in the urethra of experimental animals.
About the Authors
Sergei V. PinchukBelarus
Pinchuk Sergei Vladimirovich – Ph. D. (Biology), Senior researcher
27, Akademicheskaya Str., 220072, Minsk
Alla Yu. Molchanova
Belarus
Molchanova Alla Yur’evna – Ph. D. (Biology), Head of the Laboratory
28, Akademicheskaya Str., 220072, Minsk
Irina B. Vasilevich
Belarus
Vasilevich Irina Borisovna – Researcher
27, Akademicheskaya Str., 220072, Minsk
Irina P. Zhavoronok
Belarus
Zhavoronok Irina Petrovna – Ph. D. (Biology), Senior researcher
28, Akademicheskaya Str., 220072, Minsk
Elena I. Pekhtereva
Belarus
Pehtereva Elena Ivanovna – Juniour researcher
28, Akademicheskaya Str., 220072, Minsk
Olga A. Antipova
Belarus
Antipova Olga Aleksandrovna – Juniour researcher
28, Akademicheskaya Str., 220072, Minsk
Iosif F. Zalutski
Belarus
Corresponding Member
Igor D. Volotovski
Belarus
Volotovski Igor Dmitrievich – Academician, D. Sc. (Biology), Professor, Head of the Laboratory
27, Akademicheskaya Str., 220072, Minsk
References
1. Melville J., katon V., Delaney k., Newton k. Urinary incontinence in US women: A population-based study. Archives of Internal Medicine, 2005, vol. 165, no. 5, pp. 537–542. https://doi.org/10.1001/archinte.165.5.537
2. Markland A. D., Goode P. S., Redden D. T., Borrud L. G., Burgio k. L. Prevalence of urinary incontinence in men: results from the national health and nutrition examination survey. Journal of Urology, 2010, vol. 184, no. 3, pp. 1022–1027. https://doi.org/10.1016/j.juro.2010.05.025
3. Tran C., Damaser M. The potential role of stem cells in the treatment of urinary incontinence. Therapeutic Advances in Urology, 2015, vol. 7, no. 1, pp. 22–40. https://doi.org/10.1177/1756287214553968
4. Gotoh M., yamamoto T., kato M., Majima T., Toriyama k., kamei y., Matsukawa y., Hirakawa A., Funahashi y. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. International Journal of Urology, 2014, vol. 21, no. 3, pp. 294–300. https://doi.org/10.1111/iju.12266
5. Rodríguez L. V., Chen S., Jack G. S., de Almeida F., Lee k. W., Zhang R. New objective measures to quantify stress urinary incontinence in a novel durable animal model of intrinsic sphincter defciency. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 2005, vol. 288, no. 5, pp. 1332–1338. https://doi.org/10.1152/ajpregu.00760.2004
6. Sun L. y., Hsieh D. k., Syu W. S., Li y. S., Chiu H. T., Chiou T. W. Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential. Cell Proliferation, 2010, vol. 43, no. 5, pp. 445–456. https://doi.org/10.1111/j.1365-2184.2010.00694.x
7. yuan y., kallos M. S., Hunter C., Sen A. Improved expansion of human bone marrow-derived mesenchymal stem cells in microcarrier-based suspension culture. Journal of Tissue Engineering and Regenerative Medicine, 2014, vol. 8, no. 3, pp. 210–225. https://doi.org/10.1002/term.1515
8. Zhao W., Zhang C., Jin C., Zhang Z., Kong D., Xu W., Xiu y. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. European Urology, 2011, vol. 59, no. 1, pp. 155–163. https://doi.org/10.1016/j.eururo.2010.10.038
9. Lin G., Wang G., Banie L., Ning H., Shindel A. W., Fandel T. M., Lue T. F., Lin C. S. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy, 2010, vol. 12, no. 1, pp. 88–95. https://doi.org/10.3109/14653240903350265